This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a cyclopropylamine group attached to a fluorophenyl ring, makes it valuable in the development of drugs targeting the central nervous system (CNS), particularly for conditions like depression, anxiety, and other mood disorders. The fluorine atom enhances the molecule's bioavailability and metabolic stability, which is crucial for improving drug efficacy. Additionally, it is explored in research for potential applications in creating novel antidepressants and anxiolytics due to its ability to interact with serotonin and other neurotransmitter systems. Its unique chemical properties also make it a candidate for developing compounds with neuroprotective effects.